Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
about
Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data RegistryNovel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome.Evaluating the effectiveness of a rapidly adopted cardiovascular technology with administrative data: the case of drug-eluting stents for acute coronary syndromes.Risk-benefit trade-offs in revascularisation choices.Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention.Impact of diabetes among revascularized patients in Japan and the U.S.Clinical Outcomes of Bioresorbable Scaffold in Coronary Artery Disease: A Systematic Literature Review.Palliative care consultations for heart failure patients: how many, when, and why?Are there symptom differences in patients with coronary artery disease presenting to the ED ultimately diagnosed with or without ACS?Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.The impact of drug eluting stents availability on the treatment choice among medical therapy, percutaneous or surgical revascularisation and on 4-year clinical outcome in patients with coronary artery disease: a cohort study.Technology Diffusion and Productivity Growth in Health Care.External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008.Comparative effectiveness of carotid arterial stenting versus endarterectomyTrends in PCI volume after negative results from the COURAGE trialExtended Outcomes of Complex Coronary Disease in the Drug Eluting Stent Era.The Effect of Physician and Hospital Market Structure on Medical Technology Diffusion.Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention.Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents.Changes to polymer surface of drug-eluting stents during balloon expansion.Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: the NINETY.Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study.
P2860
Q31021002-08D1D2FB-E5FB-483C-BE4D-955E5D0CD699Q33437306-4E1EDCBC-9CAD-4BB8-9678-20654C4D6EF5Q33781277-06DE0EB4-5F2E-420D-9E6B-96E5A161A6FAQ34373214-8FAF2F13-77C3-4DD7-8BF0-DD89DF3EEE58Q34700769-F14AE79F-B08A-41B2-8B68-8C07AED4D4AEQ34719102-F66C50EA-510C-4DCD-80CC-E5F847B8D9B7Q35879154-3BA0F98E-B796-4588-96ED-164126858307Q35884429-69BD048C-831B-4C30-A8BF-272299BFABA9Q36041563-686FE3EA-CD46-4871-AAF9-5F1A4A37F3F3Q36198928-3304E0AD-121A-486C-95CE-40D1B3E1E133Q36204864-6577AF4D-8791-4837-87EC-FC63E6AF216BQ36370391-9C27D636-4075-471E-B0A1-9AEB978E8EF7Q36687809-90B1CCB3-6527-4E13-9869-5A7E8A00E14BQ36925442-ADF1C882-7E36-46FE-9291-71DC47F4F453Q37438681-178BFBD0-CBEA-473A-B31B-3BE42EBBD456Q37580425-1EB9BBA4-A1C7-4DB4-9493-73227E9817D2Q37711530-6580E8FE-43F3-486E-846D-4A2545526690Q38838423-877A206D-3D2A-403D-973A-53C7737BEEB6Q41872107-1CFE7FDA-CD55-4F61-9C31-BFB488AF026EQ45945747-F75AF3DD-F8B5-4280-A0F2-6032DD0EF6A4Q47145442-7D4AAD5A-ABEF-4386-A4A1-E8EEFDFD5892Q47880131-06906356-BB4C-4661-BC21-13A807F5D270Q53210801-05E535DC-AC26-48DE-9A29-E5A2367EBD0A
P2860
Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Outcomes following coronary st ...... he era of drug-eluting stents.
@ast
Outcomes following coronary st ...... he era of drug-eluting stents.
@en
type
label
Outcomes following coronary st ...... he era of drug-eluting stents.
@ast
Outcomes following coronary st ...... he era of drug-eluting stents.
@en
prefLabel
Outcomes following coronary st ...... he era of drug-eluting stents.
@ast
Outcomes following coronary st ...... he era of drug-eluting stents.
@en
P2093
P2860
P356
P1476
Outcomes following coronary st ...... he era of drug-eluting stents.
@en
P2093
Aaron V Kaplan
David J Malenka
F Lee Lucas
Jonathan S Skinner
Sandra M Sharp
P2860
P304
P356
10.1001/JAMA.299.24.2868
P407
P577
2008-06-01T00:00:00Z